- Markets
- Healthcare
- SANJIVIN
SANJIVIN
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Sanjivani Paranteral Says Hitesh Rajnikant Khona Resigns As CFO
April 8 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
SANJIVANI PARANTERAL LTD - HITESH RAJNIKANT KHONA RESIGNS AS CFO
SANJIVANI PARANTERAL LTD - PRITESH JAIN NAMED AS CFO
Source text for Eikon: ID:nBSE7BvW5P
Further company coverage: SANJ.BO
(([email protected];))
April 8 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
SANJIVANI PARANTERAL LTD - HITESH RAJNIKANT KHONA RESIGNS AS CFO
SANJIVANI PARANTERAL LTD - PRITESH JAIN NAMED AS CFO
Source text for Eikon: ID:nBSE7BvW5P
Further company coverage: SANJ.BO
(([email protected];))
Sanjivani Paranteral Approves Issuance Of Shares And Convertible Warrants
Dec 25 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
APPROVED ISSUANCE OF CONVERTIBLE WARRANTS
ISSUANCE OF CONVERTIBLE WARRANTS WORTH UP TO 81.1 MILLION RUPEES
APPROVED ISSUANCE OF EQUITY SHARES WORTH UP TO 227.8 MILLION RUPEES
TO ISSUE WARRANTS TO PROMOTER ON PREFERENTIAL BASIS
TO ISSUE EQUITY SHARES ON PREFERENTIAL BASIS
Source text for Eikon: ID:nBSE239xQL
Further company coverage: SANJ.BO
(([email protected];;))
Dec 25 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
APPROVED ISSUANCE OF CONVERTIBLE WARRANTS
ISSUANCE OF CONVERTIBLE WARRANTS WORTH UP TO 81.1 MILLION RUPEES
APPROVED ISSUANCE OF EQUITY SHARES WORTH UP TO 227.8 MILLION RUPEES
TO ISSUE WARRANTS TO PROMOTER ON PREFERENTIAL BASIS
TO ISSUE EQUITY SHARES ON PREFERENTIAL BASIS
Source text for Eikon: ID:nBSE239xQL
Further company coverage: SANJ.BO
(([email protected];;))
Sanjivani Paranteral To Consider Proposal To Raise Resources
Dec 19 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
TO CONSIDER PROPOSAL TO RAISE RESOURCES
Source text for Eikon: ID:nBSE11kd9s
Further company coverage: SANJ.BO
(([email protected];))
Dec 19 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
TO CONSIDER PROPOSAL TO RAISE RESOURCES
Source text for Eikon: ID:nBSE11kd9s
Further company coverage: SANJ.BO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Sanjivani Paranteral do?
Sanjivani Paranteral Ltd is an international pharmaceutical company offering a diverse range of high-quality and affordable products such as oral solids, small volume parenterals, and sterile powder formulations.
Who are the competitors of Sanjivani Paranteral?
Sanjivani Paranteral major competitors are Ambalal Sarabhai Ent, Trident Lifeline, Everest Organics, Oxygenta Pharma, Gennex Lab, Fredun Pharma, Kappac Pharma. Market Cap of Sanjivani Paranteral is ₹297 Crs. While the median market cap of its peers are ₹310 Crs.
Is Sanjivani Paranteral financially stable compared to its competitors?
Sanjivani Paranteral seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Sanjivani Paranteral pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Sanjivani Paranteral latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Sanjivani Paranteral allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments
How strong is Sanjivani Paranteral balance sheet?
Balance sheet of Sanjivani Paranteral is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Sanjivani Paranteral improving?
Yes, profit is increasing. The profit of Sanjivani Paranteral is ₹7.17 Crs for TTM, ₹6.17 Crs for Mar 2024 and ₹4.51 Crs for Mar 2023.
Is the debt of Sanjivani Paranteral increasing or decreasing?
Yes, The debt of Sanjivani Paranteral is increasing. Latest debt of Sanjivani Paranteral is ₹2.01 Crs as of Sep-24. This is greater than Mar-24 when it was -₹18.14 Crs.
Is Sanjivani Paranteral stock expensive?
Yes, Sanjivani Paranteral is expensive. Latest PE of Sanjivani Paranteral is 41.41, while 3 year average PE is 19.98. Also latest EV/EBITDA of Sanjivani Paranteral is 30.21 while 3yr average is 18.74.
Has the share price of Sanjivani Paranteral grown faster than its competition?
Sanjivani Paranteral has given better returns compared to its competitors. Sanjivani Paranteral has grown at ~114.59% over the last 2yrs while peers have grown at a median rate of 35.29%
Is the promoter bullish about Sanjivani Paranteral?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 28.87% and last quarter promoter holding is 27.67%.
Are mutual funds buying/selling Sanjivani Paranteral?
There is Insufficient data to gauge this.